Cerevel Therapeutics (CERE)
(Delayed Data from NSDQ)
$42.24 USD
+0.18 (0.43%)
Updated May 14, 2024 04:00 PM ET
After-Market: $42.20 -0.04 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Earnings News For CERE
-
Cerevel Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
-
Cerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
-
Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results
-
Cerevel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
-
Cerevel Therapeutics Reports Third Quarter 2022 Financial Results and Business Updates